Aldeyra Therapeutics Inc. (ALDX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Aldeyra Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$0.68
+6.61% today
Market cap
$39M
Overall quality
60/100
Kronos AI 30-day
—
Aldeyra Therapeutics Inc. (ALDX) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $39M. It trades at $0.68, up 6.61% today. Its overall quality score is 60 out of 100, ranked against the whole US market. 1 analysts' average target of $2.00 implies +194.1% from today's price.
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $2.00 |
| Low – high | $2.00 – $2.00 |
| Analysts | 1 |
| Upside to average | +194.1% |
Kronos AI 30-day forecast
No forecast for this listing.
Quality scores
| Profitability | 40 |
| Solvency | 92 |
| Growth | 49 |
| Overall | 60 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.